AKBA — Akebia Therapeutics Inc

Ownership history in MPM BioImpact LLC  ·  2 quarters on record

This page tracks every 13F SEC filing in which MPM BioImpact LLC reported a position in Akebia Therapeutics Inc (AKBA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.82% (2025 Q2)
Avg. % of fund
1.56%
First filed
2025 Q2
Last filed
2025 Q3
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 2,889,125 — 0% 1.29% $7.9M $2.73
2025 Q2 INITIATED 2,889,125 — — 1.82% $10.5M $3.64
% of Fund (quarterly)    AKBA price (monthly, adj. close)

Other funds also holding AKBA

As of 2025 Q4 — sorted by position size

Nantahala Capital Management, LLC 3Y 7Y 0.11% EntryPoint Capital, LLC 0.08% Orchard Capital Management, LLC 3Y 0.07% OXFORD ASSET MANAGEMENT LLP 3Y 7Y 0.07% nVerses Capital, LLC 0.04% Round Rock Advisors LLC 3Y 0.04% Hennion & Walsh Asset Management, Inc. 3Y 0.03% NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 3Y 7Y 0.02% XTX Topco Ltd 3Y 0.02% Empirical Asset Management, LLC 3Y 0.02%
← Back to MPM BioImpact LLC Holdings